新冠肺炎疫苗接种后局部注射反应、黄斑部皮疹和红斑痤疮加重

Q3 Medicine

Case Reports in Dermatological Medicine Pub Date : 2022-04-14 DOI:10.1155/2022/9944727

Youness Benyamna, F. Marraha, I. Al Faker, H. Chahoub, Najlae Rahmani, Yasmine Rkiek, Soukayna Kabbou, D. Soussi Tanani, S. Gallouj

{"title":"新冠肺炎疫苗接种后局部注射反应、黄斑部皮疹和红斑痤疮加重","authors":"Youness Benyamna, F. Marraha, I. Al Faker, H. Chahoub, Najlae Rahmani, Yasmine Rkiek, Soukayna Kabbou, D. Soussi Tanani, S. Gallouj","doi":"10.1155/2022/9944727","DOIUrl":null,"url":null,"abstract":"To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneous manifestations (maculopapular exanthem with enanthem, site injection reaction, and rosacea exacerbation) occurring three days after taking the first dose of AstraZeneca AZD1222 vaccine.","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination\",\"authors\":\"Youness Benyamna, F. Marraha, I. Al Faker, H. Chahoub, Najlae Rahmani, Yasmine Rkiek, Soukayna Kabbou, D. Soussi Tanani, S. Gallouj\",\"doi\":\"10.1155/2022/9944727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneous manifestations (maculopapular exanthem with enanthem, site injection reaction, and rosacea exacerbation) occurring three days after taking the first dose of AstraZeneca AZD1222 vaccine.\",\"PeriodicalId\":9630,\"journal\":{\"name\":\"Case Reports in Dermatological Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Dermatological Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2022/9944727\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Dermatological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/9944727","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

迄今为止，新冠肺炎疫苗接种后发生的不良事件很少，其报告仍然很差；然而，因果关系评估是为了确定相关的原因，如果它们发生了。在本病例报告中，我们报告了一例在接种第一剂阿斯利康AZD1222疫苗三天后出现的三种皮肤表现（斑丘疹伴对映体、局部注射反应和酒渣鼻恶化）相关的病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination

To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneous manifestations (maculopapular exanthem with enanthem, site injection reaction, and rosacea exacerbation) occurring three days after taking the first dose of AstraZeneca AZD1222 vaccine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Case Reports in Dermatological Medicine Medicine-Dermatology

CiteScore

1.50

自引率

0.00%

发文量

审稿时长

15 weeks